Laura Gover, Andrew Anguko, Jane Bruce, Godfrey Magumba, et al.
1
Laurence Cibrelus
1
Ledikwe, J.H., Kejelepula, M., Maupo, K., et al.
1
Lena Morgon Banks and Sarah Polack
1
Lesotho National AIDS Commission, Government of Lesotho
1
Llyod, A.
1
Lucerne University
1
Lucinda Ramos
1
Lukito, A.A., A.U. Rahajoe, L.I. Rilantono, et al.,
1
M. Ballard, Bancroft E., Nesbit J., et al.
1
M. Beusenberg et al.
1
M. Doara, D. Choroliani, P. de Colombani
1
M. Doherty
1
M. F. Silveira
1
M. Gallardo, et al.
1
M. Ghidinelli
1
M. Holtmann
1
M. Joffres
1
M. Kan
1
M. Manova
1
M. Mansfeld
1
M. Penazzato
1
M. R. Jordan
1
M. Semrau
1
M. SHOWKAT GANI et al.
1
M. SHOWKAT GANI, MAL ABIKA SARKER, BULBUL ASHRAF SIDDIQI, ILIA S MAHMUD,YAMIN TAUSEEF JAHANGIR, SA LLY THEOBALD, HERMEN ORM EL, SALAUDDIN BISWAS , KUHEL FAIZUL ISLAM, SUBORN A CAMELLIA, SABINA F AIZ RASHID
1
M. Smelyanskaya, J. Duncan
1
M. Sundararaj
1
M. van den Boom
1
M.-R. B-Lajoie
1
M.Johnson
1
M.N. Ngongondo
1
MacQuarrie, Kerry L.D., Rebecca Winter, and Sunita Kishor
1
MacQuarrie, Kerry L.D., Sarah E.K. Bradley, Alison Gemmill, and Sarah Staveteig
1
Mairie de Paris
1
Makatjane, T. J., T. Hlabana, and E. M. Letete
1
Malaria Consortium
1
Malaria Journal
1
Malawi Ministry of Health (MOH), Save the Children
1
Management Sciences for Health
1
March of Dimes
1
Marie-Luise Abshagen, Anna Cavazzini, Laura Graen, Wolfgang Obenland
1
Mark F. Cotton
1
Mark W. Rosegrant | Jawoo Koo | Nicola Cenacchi
1
Mary De Silva, Lucy Lee& Grace Ryan
1
Mary-Anne Hartley, Alyssa Young, Anh-Minh Tran et al.
1
Marzouk M., Rayes D., Y. Douedari et al.
1
Massoda Tonye, S.G.
1
Maurice Bucagu, Jean M. Kagubare, Paulin Basinga, Fidèle Ngabo, Barbara K Timmons & Angela C Lee
1
McGahey, Christopher
1
MCNV, Global Initiative on Psychiatry, and World Granny
1
Measles Initiative
1
Medecins Sans Frontiers
1
Mediscript Ltd
1
Melanie Duncan, et al.
1
Mental, Neurological, and Substance Use Disorders: Disease Control Priorities, Third Edition (Volume 4).
1
Mèdecines sans Frontières MSF
1
Médecins Sans Frontières (MSF)
1
MHFA
1
mhGAP
1
Michael T. Osterholma, Kristine A. Moorea, Nicholas S. Kelley et al.
1
Mike Wessells
1
Miller, C.
1
Ministerio de sanidad - España
1
Ministère de la Santé et de l’Action Sociale et Ministère de la Justice
1
Ministry of Health
1
Ministry of Health & Child Welfare
1
Ministry of Health & Family Welfare, India, et al.
1
Ministry of Health and Family Welfare Government of the People's Republic of Bangladesh
1
Ministry of Health and Family Welfare, Directorate-General of Health Services, Mycobacterial Disease Control, National Tuberculosis Control Programme
1
Ministry of Health and Social Welfare, Central TB Division, India
1
Ministry of Health and Social Welfare, Government of India
1
Ministry of Health Ethiopia
1
Ministry of Health Ghana
1
Ministry of Health Uganda, NADIC, et al.
1
Ministry of Health, Ethiopia
1
Ministry of Health, Federal Democratic Republic of Ethiopia
1
Ministry of Health, Gabarone, Botswana
1
Ministry of Health, Ghana
1
Ministry of Health, Government of Kenya
1
Ministry of Health, Government of Liberia
1
Ministry of Health, Kenya
1
Ministry of Health, Liberia
1
Ministry of Health, Malawi
1
Ministry of Health, Pakistan
1
Ministry of Health, Republic of Kenya
1
Ministry of Health, Republic of Rwanda
1
Ministry of Health, Republic of South Africa
1
Ministry of Health, Rwanda
1
Ministry of Health, Rwanda & Rwanda Biomedical Centre
1
Ministry of Health, South Africa
1
Ministry of Health, Uganda
1
Ministry of Health, Zambia
1
Ministry of Public Health, Quatar
1
Missionalia
1
Mjelde, Marit
1
Mock, Charles N.
1
Mont, D.
1
MSF Access Campaign
1
MSMGF
1
Muller, Helgard et al.
1
Murphy, Ben
1
Myanmar Climate Change Alliance (MCCA)
1
Myanmar, Ministry of Health and Sports
1
N. Abera, T. Saballa, et al.
1
N. B. Ahmed
1
N. Bellare
1
N. C. Rollins
1
N. K. Arora
1
N. Mdaka
1
N. Reuge and D. Amaro
1
N.Dean
1
N.V. Salabai
1
NACO, Department of AIDS Control
1
NADMO Ghana
1
NASTAD Zambia
1
National Academy of Sciences of the USA
1
National Agency for Control of AIDS (NACA)
1
National Agency for the Control of AIDS (NACA), Government of Nigeria
1
National AIDS Commission (NAC)
1
National AIDS Commission of Liberia
1
National AIDS Control Organization (NACO), United Nations Development Programme (UNDP)
1
National AIDS Control Program
1
National HIV and AIDS Secretariat
1
National HIVAIDS Council Zambia
1
National Institute of Disaster Management (India)
1
National Institute of Disaster Management (NIDM), Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ)
1
National Institute of Health
1
National Malaria Elimination Centre, Ministry of Health, Zambia
1
National Malaria Elimination Programme Federal Ministry of Health National Population Commission, National Bureau of Statistics Federal Republic of Nigeria , et al.
1
National Polio Emergency Operations Centre (EOC), Islamabad, Pakistan
1
National Primary Health Care Development Agency
1
National TB Control Programme, Bangladesh
1
National Tuberculosis Leprosy and Lung Disease Program (NTLD-program), Ministry of Health, Republic of Kenya
1
ndia State-Level Disease Burden Initiative Cancer Collaborators
1
Neil M Ferguson, Daniel Laydon, Gemma Nedjati-Gilani, Natsuko Imai, Kylie Ainslie, Marc Baguelin, Sangeeta Bhatia, Adhiratha Boonyasiri, Zulma Cucunubá, Gina Cuomo-Dannenburg, Amy Dighe, Ilaria Dorigatti, Han Fu, Katy Gaythorpe, Will Green, Arran Hamlet, Wes Hinsley, Lucy C Okell, Sabine van Elsland, Hayley Thompson, Robert Verity, Erik Volz, Haowei Wang, Yuanrong Wang, Patrick GT Walker, Caroline Walters, Peter Winskill, Charles Whittaker, Christl A Donnelly, Steven Riley, Azra C Ghani.
1
Nepal Journal of Obstetrics and Gynaecology (NJOG)
1
Nepal Ministry of Health and Population, New ERA, and ICF International
1
Nesheim, Ingrid
1
Net Hope
1
Niederberger, E.
1
Norsk institutt for vannforskning (NIVA)
1
Norwegian Refugee Council, Internal Displacement Monitoring Centre
1
NSW Health and University of Western Sydney
1
Nugent, Rachel
1
Nugroho
1
Nunn, Marc
1
O. Drouin
1
O. Samoylova
1
O.M. Balakireva
1
Observatorio Regional de Recursos Humanos de Salud
1
Office for the Coordination of Humanitarian Affairs OCHA
1
ohns Hopkins Center for Communication Programs
1
Olney, Jack J.
1
ONUSIDA
1
OpenLearn Create
1
Organización Mundial de la Salud (Américas)
1
Organización Mundial de la Salud OMS
1
OSF and OSISA the Centre for Human RightsPretoria University Law Press (PULP)
2nd edition. The 2018 Roadmap incorporates an additional critical population: adolescents. Despite making up 1 in 6 of the world’s people, adolescents have been largely overlooked as global momentum to address TB has grown. Spanning the ages of 10–19 years, adolescents are both at risk of TB and... represent an important population for TB control. They often present with infectious TB and frequently have multiple contacts in congregate settings, such as schools and other educational institutions. Nevertheless, few countries capture TB data in suitably age-disaggregated ways to allow full understanding of its impact in this group and even fewer provide the adolescent-friendly services our young people need to access diagnosis and care.more
Lymphatic filariasis is a vector-borne neglected tropical disease that causes damage of the lymphatic system and can lead to lymphoedema (elephantiasis) and hydrocele in infected individuals. The global baseline estimate of persons affected by lymphatic filariasis is 25 million men with hydrocele an...d over 15 million people with lymphoedema. At least 36 million persons remain with these chronic disease manifestations. The disease is endemic in 72 countries. In 2016, an estimated total population of 856 million were living in areas with ongoing transmission of the causative filarial parasites and requiring mass drug administration (MDA). Lymphatic filariasis disfigures and disables, and often leads to stigmatization and poverty. Hundreds of millions of dollars are lost annually due to reduced productivity of affected patients. WHO has ranked the disease as one of the world’s leading causes of permanent and long-term disability.more
n light of the potential risk posed by SARS-CoV-2 variants, in January 2021 WHO organized an ad hoc consultation to discuss the development of an R&D agenda in response to existing and emerging SARS-CoV-2 variants.
The key objectives were to identify the critical research questions related to var...iants and agree on a research approach to address them. Six breakout groups covered a range of specific issues related to COVID-19 variants: Epidemiology and mathematical modelling; evolutionary biology; animal models; assays and diagnostics; clinical management and therapeutics; and vaccines.
This report is a summary of presentations and panel discussions.more
5 May 2021
This Information Note is intended to assist national TB programmes and health personnel worldwide to maintain essential tuberculosis (TB) services during the COVID-19 pandemic and in the recovery phase. It is important that recent progress made in TB prevention and care is not reversed b...y COVID-19. The WHO Global TB Programme, along with WHO regional and country offices, developed this note in response to questions received from Member States and other partners since the start of the pandemic. The note includes references to other published WHO information products relevant to TB practitioners. WHO continues to monitor the situation closely for any changes that may influence this note and will issue updates should any factors change.more
The menu was developed using the WHO-CHOICE methodology to prepare and update, as appropriate, WHO estimates of the cost-effectiveness of a range of mental health interventions, in line with the development of Appendix 3 to the global action plan for the prevention and control of noncommunicable dis...eases 2013–2020.
WHO-CHOICE is a programme that helps countries to identify priorities based on health impact and cost-effectiveness. It can be applied to a wide range of strategies relevant to policies affecting health outcomes. All options are compared to a common comparator, a null scenario in which the impacts of currently implemented interventions are removed, thereby enabling comparison of interventions across geographical areas and aspects of health.more
Development of one or more vaccines for Neisseria gonorrhoeae is an important objective for sexual and reproductive health worldwide, and for the fight against antimicrobial resistance.
WHO preferred product characteristics (PPCs) provide strategic guidance as to WHO’s preferences for new vacci...nes in priority disease areas. PPCs are intended to encourage innovation and development of vaccines for use in settings most relevant to the global unmet public health need.
Gonococcal vaccine PPCs describe global public health goals for gonococcal vaccines and preferred parameters pertaining to vaccine indications and target populations, safety and efficacy considerations, and immunization strategies.more
The Lancet Countdown is an international collaboration that independently monitors the health consequences of a changing climate. Publishing updated, new, and improved indicators each year, the Lancet Countdown represents the
consensus of leading researchers from 43 academic institutions and UN ag...encies. The 44 indicators of this report expose an unabated rise in the health impacts of
climate change and the current health consequences of the delayed and inconsistent response of countries around the globe—providing a clear imperative for accelerated action that puts the health of people and planet above all else.The 2021 report coincides with the UN Framework Convention on Climate Change 26th Conference of the Parties (COP26), at which countries are facing pressure to realise the ambition of the Paris Agreement to keep the global average temperature rise to 1·5°C and to
mobilise the financial resources required for all countries to have an effective climate response. These negotiations unfold in the context of the COVID-19 pandemic—a global health crisis that has claimed millions of lives, affected livelihoods and communities around the globe, and exposed deep fissures and inequities in the world’s capacity to cope with, and respond to, health emergencies. Yet, in its response to both crises, the world is faced with an unprecedented opportunity to ensure a healthy future for all.more
N Engl J Med 2022; 386:911-922, DOI: 10.1056/NEJMoa2104535
Four months of antituberculosis treatment was noninferior to 6 months of treatment in children with drug-susceptible, nonsevere, smear-negative tuberculosis (SHINE Study)
During the first year of the Covid-19 pandemic, the world’s economy slowed. Yet, the global annual average particulate pollution (PM2.5) was largely unchanged from 2019 levels. At the same time, growing evidence shows air pollution—even when experienced at very low levels—hurts human health. T...his recently led the World Health Organization (WHO) to revise its guideline for what it considers a safe level of exposure of particulate pollution, bringing most of the world—97.3 percent of the global population—into the unsafe zone. The AQLI finds that particulate air pollution takes 2.2 years off global average life expectancy, or a combined 17 billion life-years, relative to a world that met the WHO guideline. This impact on life expectancy is comparable to that of smoking, more than three times that of alcohol use and unsafe water, six times that of HIV/AIDS, and 89 times that of conflict and terrorism.more
The new treatment recommendations that extend the 2018 treat all recommendation for adults with chronic HCV infection to include adolescents and children down to 3 years, and to align the existing recommended pangenotypic direct-acting antiviral (DAA) regimens (SOF/DCV, SOF/VEL and G/P) for adults, ...to those for adolescents and children. This alignment is expected to simplify procurement, promote access to treatment among children in low- and middle-income countries and contribute to global efforts to eliminate the diseasemore
This document sets out, therefore, to explain the socioeconomic value of investing in the fight against NTDs and highlights priorities for global investment attention. Our work was guided by the need not only for
additional funding and funders but also for the need to understand the current funding... climate, in which value for money and the efficient use of resources to fill the most critical of gaps are more relevant than ever.more
Many countries have made significant progress in the implementation of World Health Organization recommended preventive chemotherapy strategy, to eliminate lymphatic filariasis (LF). However, pertinent challenges such as the existence of areas of residual infections in disease endemic districts pose... potential threats to the achievements made. Thus, this study was undertaken to assess the importance of these areas in implementation units (districts) where microfilaria (MF) positive individuals could not be found during the mid-term assessment after three rounds of mass drug administration.more
As part of the UN’s data strategy—which seeks to nurture data as a strategic asset for insight, impact and integrity—UNAIDS plays an indispensable role in generating data for effective action against the AIDS pandemic. It leads the
world’s most extensive data collection on HIV epidemiology,... programme coverage, policy and finance, and it publishes the most authoritative and up-to-date information on the HIV pandemic and response. The UNAIDS database of countryreported data is a foundational pillar for global and regional AIDS programmes, research, advocacy and resource mobilizationmore
This document summarizes the results of the WHO-commissioned full value proposition for new tuberculosis (TB) vaccines. The assessment was commissioned to provide early evidence for national and global decision-makers involved in TB vaccine development and implementation, who include stakeholders in...volved in vaccine research, financing, regulation and policy-making, manufacturing, introduction and procurement. The goal is to accelerate development of effective vaccines against TB and their rapid introduction into countries.more
Obesity and diet-related noncommunicable diseases (NCDs) have been steadily increasing globally, and with them, a pressing need to implement effective responses to address the contributing factors. Among the available evidence-based policy options that enable healthier choices and improved diets is ...the implementation of taxes on sugar-sweetened beverages (SSBs).
This tax manual is a practical guide for policy-makers and others involved in SSB tax policy development to promote healthy diets and populations. It features summaries and case studies of SSB global taxation evidence, and provides support on the policy-cycle development process to implement SSB taxation — from problem identification and situation analysis through policy design, development and implementation to the monitoring and evaluation phase. Additionally, the manual identifies and debunks industry tactics designed to dissuade policy-makers from implementing these taxes.
SSB taxes can be a win-win-win strategy: a win for public health (and averted health-care costs), a win for government revenue, and a win for health equity.more
The Strategic Advisory Group of Experts (SAGE) on Immunization held a meeting on 3-6 October 2022. This report summarizes the discussions, conclusions and recommendations.
It covers the following items:
Global Reports
Immunization Agenda 2030 and Regional reports
Monkeypox
RSV
COVID-19 vacci...nes
Polio vaccination
Ebola (Sudan ebolavirus outbreak update)more
Nearly 260 000 people died in parts of Somalia between October 2010 and April 2012, including
133 000 children under five during the famine and food crisis in Somalia making it the worst famine in history.
A study commissioned and funded by the Food and Agriculture Organization of the United Natio...n’s food security and nutrition analysis unit for Somalia stated that the famine early warning systems clearly identified the risk of famine in South Central Somalia in 2010–2011 but timely action to prevent the onset of famine was not taken. The result was large scale
mortality, morbidity and population displacement.more
The WHO continuously reviews available data on SARS-CoV-2 variants of concern. For this version, the global epidemiological
situation of the COVID-19 pandemic as of 21 January 2022 – at a time when the Omicron VOC had been identified in 171
countries across all six WHO Regions and was rapidly re...placing Delta worldwide – was considered Omicron has a substantial growth advantage, higher secondary attack rates and a higher observed reproduction number than Delta.
There is now significant evidence that immune evasion contributes to the rapid spread of Omicron. Other factors may be a shorter
serial interval (by about 0.8 to 1.2 days compared to Delta) and potential increased intrinsic transmission fitness . There is
growing evidence that with Omicron, there is lower vaccine effectiveness (VE) against infection and symptomatic disease soon after vaccination compared to Delta. There is also evidence of accelerated waning of VE over time of the primary series against infection and symptomatic disease for the studied vaccines. Further studies are required to better understand the drivers of transmission and declining incidence in various settings. These factors include the intrinsic transmission fitness properties of the virus, degree of immune evasion, vaccination coverage and level of vaccine-derived and post-infection immunity, levels of social mixing and degree of application of public health and social measures (PHSM).more
About one fourth of the world’s population is estimated to have been infected with the tuberculosis (TB) bacilli, and about 5–10% of those infected develop TB disease in their lifetime. The risk for TB disease after infection depends on several factors, the most important being the person’s im...munological status. TB preventive treatment (TPT) given to people at highest risk of progressing from TB infection to disease remains a critical element to achieve the global targets of the End TB Strategy, as reiterated by the second UN High Level Meeting on TB in 2023. Delivering TPT effectively and safely necessitates a programmatic approach to implement a comprehensive package of interventions along a cascade of care: identifying individuals at highest risk, screening for TB and ruling out TB disease, testing for TB infection, and choosing the preventive treatment option that is best suited to an individual, managing adverse events, supporting medication adherence and monitoring programmatic performance.more
About one fourth of the world’s population is estimated to have been infected with the tuberculosis (TB) bacilli, and about 5–10% of those infected develop TB disease in their lifetime. The risk for TB disease after infection depends on several factors, the most important being the person’s im...munological status. TB preventive treatment (TPT) given to people at highest risk of progressing from TB infection to disease remains a critical element to achieve the global targets of the End TB Strategy, as reiterated by the second UN High Level Meeting on TB in 2023. Delivering TPT effectively and safely necessitates a programmatic approach to implement a comprehensive package of interventions along a cascade of care: identifying individuals at highest risk, screening for TB and ruling out TB disease, testing for TB infection, and choosing the preventive treatment option that is best suited to an individual, managing adverse events, supporting medication adherence and monitoring programmatic performancemore